Conexeu Sciences Inc. Common Stock (CNXU)

Conexeu Sciences Inc. Common Stock (CNXU) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $93.4M; returns 1 day -6.1%, 1 week +1.3%.

Conexeu Sciences Inc. (CNXU) is a preclinical-stage regenerative medicine and biotechnology company headquartered in Reno, Nevada. The company is built around its proprietary CXU™ platform, a patented collagen-based extracellular matrix (ECM) and hydrogel scaffold technology designed to transition from a liquid to a gel state at body temperature.

Groups CNXU belongs to

• Recent IPOs
• Biotechnology
• Regenerative Medicine
• Preclinical Development
• Life Sciences
• Medical Devices
• Healthcare
• Biopharmaceutical

CNXU financial model: income statement, cash flow and balance sheet